CTNNB1 and breast cancer: Interestingly, kynurenine 3‐monooxygenase, an enzyme‐driven metabolic Kyn, acts as an oncogene in breast cancer by stimulating cells grown and invasiveness and enhances the stemness of cancer cells through beta‐catenin in breast cancer.34